Filter your results
- 2
- 2
- 4
- 4
- 1
- 1
- 2
- 4
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
HIV-Infected Dendritic Cells Present Endogenous MHC Class II–Restricted Antigens to HIV-Specific CD4 + T CellsJournal of Immunology, 2016, 197 (2), pp.517 - 532. ⟨10.4049/jimmunol.1600286⟩
Journal articles
pasteur-01401329v1
|
||
|
Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect.Journal of Virology, 2010, 84 (10), pp.5314-28. ⟨10.1128/JVI.02329-09⟩
Journal articles
pasteur-00488573v1
|
||
|
CTL Escape Mediated by Proteasomal Destruction of an HIV-1 Cryptic EpitopePLoS Pathogens, 2011, 7 (5), pp.94. ⟨10.1371/journal.ppat.1002049⟩
Journal articles
pasteur-01372493v1
|
||
|
The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.Journal of Experimental Medicine, 2010, 207 (1), pp.39-49, S1-2. ⟨10.1084/jem.20091933⟩
Journal articles
pasteur-00458098v1
|